Increased mean platelet volume in patients with vestibular migraine

Abstract

Objectives: The purpose of this study was to investigate relation between mean platelet volume, platelet distribution width, platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio and vestibular migraine.

Methods: This study was planned in prospective manner and conducted in Ankara Polatlı State Hospital between April 2017 and May 2018. Thirty patients diagnosed with vestibular migraine and thirty healthy, age and sex-matched subjects were enrolled to the study. Mean platelet volume, platelet distribution width, platelet count, neutrophil count and lymphocyte count in blood samples were measured.

Results: The mean age of the patients with vestibular migraine was 39.90 ± 7.16 and the study group consisted of 11 males and 19 females. The mean platelet volume and platelet distribution width values in patients with vestibular migraine were significantly higher than the control group (p < 0.001). There were no difference on mean neutrophil/lymphocyte ratio and platelet/lymphocyte ratio values between patient group and control group.

Conclusions: We found a positive relation of increased levels of mean platelet volume and platelet distribution width with vestibular migraine. Higher mean platelet volume is associated with atherosclerosis and thromboembolism. Vascular pathologies are blamed for both headache syndromes like migraine and vertiginous syndromes. This theory supports our study but pathophysiological mechanism is not clear. 

Keywords

• Hematologic parameters,mean platelet volume,neutrophil-to-lymphocyte ratio,platelet-to-lymphocyte ratio,vestibular migraine

References

1. 1. Lempert T, Neuhauser HK. Epidemiology of vertigo, migraine and vestibular migraine. J Neurol 2009;256:333-8.
2. 2. Baker BJ, Curtis A, Trueblood P, Vanqsnes E. Vestibular functioning and migraine: comparing those with and without vertigo to a normal population. J Laryngol Otol 2013;127:1169-76.
3. 3. Von Brevern A, Radtke A, Clarke AH, Lempert T. Migrainous vertigo presenting as episodic positional vertigo. Neurology 2004;62:469-72.
4. 4. Neuhauser HK, Radtke A, Von Brevern A, Feldmann M, Lezius F, Ziese T, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology 2006;67:1028-33.
5. 5. Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hem 2009;31:277-97.
6. 6. Machin SJ, Briggs C. Mean platelet volume: a quick easy determinant of thrombotic risk? J Thromb and Haemost 2009;8:146-7.
7. 7. Baloh RW. Neurotology of migraine. Headache 1997;37:615-21.
8. 8. Felisati G, Pipolo C, Portaleone S. Migraine and vertigo: two diseases with the same pathogenesis? Neurol Sci 2010;31:107-9.

9. 9. Killer HE, Forrer A, Flammer J. Retinal vasospasm during an attack of migraine. Retina 2003;23:253-4.
10. 10. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res 2012;22:167-72.
11. 11. Eggers SD. Migraine-related vertigo: diagnosis and treatment. Curr Pain Headache Rep 2007;11:217-26.
12. 12. Celikbilek A, Tanik N, Zarasiz G, Celikbilek M. Do platelet indices have a role in benign paroxysmal positional vertigo? Neurol Res 2014;36:763-8.
13. 13. Kemal O, Muderris T, Basar F, Kutlar G, Gül F. Prognostic value of mean platelet volume on tinnitus. J Laryngol Oto 2016;130:162-5.
14. 14. Sarıkaya Y, Bayraktar C, Karatas M¸ Dogan S, Olt S, Kaskalan E, et al. Increased mean platelet volume in patients with idiopathic subjective tinnitus. Eur Arch Otorhinolaryngol 2016;273:3533-6.
15. 15. Beyan C, Beyan E. Mean platelet volume may not be increased in patients with idiopathic subjective tinnitus. Eur Arch Otorhinolaryngol 2016;273:4035-6.
16. 16. Ulusoy B, Bozdemir K, Akyol M, Mise HI, Kutluhan A, Korkmaz MH. Investigation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and mean platelet volume in patients with tinnitus. J Laryngol Otol 2018;132:129-32.
17. 17. Ulu S, Ulu MS, Ahsen A, Yucedag F, Aycicek A, Celik S. Increased levels of mean platelet volume: a possible relationship with idiopathic sudden hearing loss. Eur Arch Otorhinolaryngol 2013;270:2875-8.
18. 18. Sagit M, Kavugudurmaz M, Guler S, Somdas MA. Impact of mean platelet volume on the occurrence and severity of sudden sensorineural hearing loss. J Laryngol Otol 2013;127:972-6.
19. 19. Durmus K, Terzi H, Karatas TD, Dogan M, Uysal IO, Sencan M, et al. Assessment of hematological factors involved in development and prognosis of idiopathic sudden sensorineural hearing loss. J Craniofacial Surg 2016;27:85-91.
20. 20. Karli R, Alacam H, Unal R, Kucuk H, Aksoy A, Ayhan E. Mean platelet volume: is it a predictive parameter in the diagnosisof sudden sensorineural hearing loss? Indian J Otolaryngol Head Neck Surg 2013;65:350-3.
21. 21. Kum RO, Özcan M, Baklacı D, Yurtsever Kum N, Yilmaz YF, Unal A, et al. Investigation of neutrophil-to-lymphocyte ratio and mean platelet volume in sudden hearing loss. Braz J Otorhinolaryngol 2015;81:636-41.
22. 22. Ozturk M, Kara A, Dasli S, Topdag M. Mean platelet volume: is it a parameter associated with idiopathic sensorineural hearing loss? Eur Arch Otorhinolaryngol 2014;271:2595-6.
23. 23. Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cesana BM, et al. Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope 2007;117:547-51.